Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population

World Journal of Gastroenterology

Volumn 21, Issue 20, 2015, Pages 6287-6295

  Kwak, Min Sun ^a   Kim, Donghee ^a   Chung, Goh Eun ^a   Kim, Won ^b   Kim, Yoon Jun ^c   Yoon, Jung Hwan ^c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Cholelithiasis; Fatty liver; Gallbladder; Gallbladder removal; Hepatic steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; BODY MASS; CARDIOMETABOLIC RISK; CHOLECYSTECTOMY; CHOLELITHIASIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PATIENT HISTORY OF CHOLECYSTECTOMY; PHYSICAL ACTIVITY; POPULATION; PREVALENCE; SMOKING; SOUTH KOREA; UNIVERSITY HOSPITAL; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; ETHNOLOGY; GALLSTONES; HEALTH SURVEY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CHOLECYSTECTOMY; CROSS-SECTIONAL STUDIES; FEMALE; GALLSTONES; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84930836889     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i20.6287     Document Type: Article

References (40)

1. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609 [PMID: 22656328 DOI: 10.1053/j.gastro.2012.04.001]
2. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2013; 19: 325-348 [PMID: 24459637 DOI: 10.3350/cmh.2013.19.4.325]
3. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013; 57: 1357-1365 [PMID: 23175136 DOI: 10.1002/hep.26156]
4. Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J Hepatol 2010; 53: 1146-1147 [PMID: 20817302 DOI: 10.1016/j.jhep.2010.06.013]
5. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-3546 [PMID: 16306373]
6. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117: 632-639 [PMID: 10464139]
7. Kratzer W, Mason RA, Kächele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999; 27: 1-7 [PMID: 9888092]
8. Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol 2012; 47: 197-203 [PMID: 22182015 DOI: 10.3109/00365521.2011.643481]
9. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am 2010; 39: 157-69, vii [PMID: 20478480 DOI: 10.1016/j.gtc.2010.02.003]
10. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Ikematsu H, Noguchi A, Tani S, Goto M. Prevalence of gallstone disease in a general population of Okinawa, Japan. Am J Epidemiol 1988; 128: 598-605 [PMID: 3046339]
11. Fracanzani AL, Valenti L, Russello M, Miele L, Bertelli C, Bellia A, Masetti C, Cefalo C, Grieco A, Marchesini G, Fargion S. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One 2012; 7: e41183 [PMID: 22848440 DOI: 10.1371/journal.pone.0041183]
12. Yilmaz Y, Ayyildiz T, Akin H, Colak Y, Ozturk O, Senates E, Tuncer I, Dolar E. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. Gut Liver 2014; 8: 313-317 [PMID: 24827629 DOI: 10.5009/gnl.2014.8.3.313]
13. Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 2013; 108: 952-958 [PMID: 23545713 DOI: 10.1038/ajg.2013.70]
14. Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, Park SW, Kim SW. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care 2011; 34: 727-729 [PMID: 21278140 DOI: 10.2337/dc10-1991]
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419 [PMID: 3899825]
16. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, Rudilosso A, D'Amico R, Bertolotti M, Carulli N. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005; 20: 1176-1184 [PMID: 16048564 DOI: 10.1111/j.1440-1746.2005.03924.x]
17. Amigo L, Husche C, Zanlungo S, Lütjohann D, Arrese M, Miquel JF, Rigotti A, Nervi F. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int 2011; 31: 52-64 [PMID: 21040411 DOI: 10.1111/j.1478-3231.2010.02361.x]
18. Friedrich N, Völzke H, Hampe J, Lerch MM, Jørgensen T. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany. Am J Gastroenterol 2009; 104: 89-95 [PMID: 19098855 DOI: 10.1038/ajg.2008.13]
19. Stokes CS, Krawczyk M, Lammert F. Gallstones: environment, lifestyle and genes. Dig Dis 2011; 29: 191-201 [PMID: 21734384 DOI: 10.1159/000323885]
20. Deurenberg P, Deurenberg-Yap M. Differences in body-composition assumptions across ethnic groups: practical consequences. Curr Opin Clin Nutr Metab Care 2001; 4: 377-383 [PMID: 11568498]
21. Wulan SN, Westerterp KR, Plasqui G. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 2010; 65: 315-319 [PMID: 20079586 DOI: 10.1016/j.maturitas.2009.12.012]
22. Almond HR, Vlahcevic ZR, Bell CC, Gregory DH, Swell L. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. N Engl J Med 1973; 289: 1213-1216 [PMID: 4748594 DOI: 10.1056/NEJM197312062892302]
23. Roda E, Aldini R, Mazzella G, Roda A, Sama C, Festi D, Barbara L. Enterohepatic circulation of bile acids after cholecystectomy. Gut 1978; 19: 640-649 [PMID: 567165]
24. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 2010; 28: 220-224 [PMID: 20460915 DOI: 10.1159/000282091]
25. Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology 2011; 53: 1023-1034 [PMID: 21319202 DOI: 10.1002/hep.24148]
26. Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol 2013; 368: 17-29 [PMID: 22609541 DOI: 10.1016/j.mce.2012.05.004]
27. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis 2011; 29: 37-44 [PMID: 21691102 DOI: 10.1159/000324126]
28. Zweers SJ, Booij KA, Komuta M, Roskams T, Gouma DJ, Jansen PL, Schaap FG. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Hepatology 2012; 55: 575-583 [PMID: 21953282 DOI: 10.1002/hep.24702]
29. Bhatnagar S, Damron HA, Hillgartner FB. Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J Biol Chem 2009; 284: 10023-10033 [PMID: 19233843 DOI: 10.1074/jbc.M808818200]
30. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, Williams PM, Soriano R, Corpuz R, Moffat B, Vandlen R, Simmons L, Foster J, Stephan JP, Tsai SP, Stewart TA. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 2004; 145: 2594-2603 [PMID: 14976145 DOI: 10.1210/en.2003-1671]
31. Alisi A, Ceccarelli S, Panera N, Prono F, Petrini S, De Stefanis C, Pezzullo M, Tozzi A, Villani A, Bedogni G, Nobili V. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease. PLoS One 2013; 8: e67160 [PMID: 23840612 DOI: 10.1371/journal.pone.0067160]
32. Barrera F, Molina H, Azocar L. Cholecystectomy changes the diurnal rhythm and reduces serum levels of FGF 19 couples with a rise in bile acid synthesis. Hepatology 2012; 54: 728A
33. Nervi F, Arrese M. Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? Am J Gastroenterol 2013; 108: 959-961 [PMID: 23735917 DOI: 10.1038/ajg.2013.84]
34. Ahmed MH, Ali A. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first? Scand J Gastroenterol 2014; 49: 521-527 [PMID: 24646400 DOI: 10.3109/00365521.2014.894119]
35. Giamberardino MA, Affaitati G, Lerza R, Lapenna D, Costantini R, Vecchiet L. Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology. Pain 2005; 114: 239-249 [PMID: 15733650 DOI: 10.1016/j.pain.2004.12.024]
36. Yener O, Aksoy F, Demir M, Özçelik A, Erengül C. Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. Turk J Gastroenterol 2010; 21: 411-415 [PMID: 21331995]
37. Krawczyk M, Miquel JF, Stokes CS, Zuniga S, Hampe J, Mittal B, Lammert F. Genetics of biliary lithiasis from an ethnic perspective. Clin Res Hepatol Gastroenterol 2013; 37: 119-125 [PMID: 23340007 DOI: 10.1016/j.clinre.2012.09.002]
38. Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998; 27: 437-441 [PMID: 9883999]
39. Singh V, Trikha B, Nain C, Singh K, Bose S. Epidemiology of gallstone disease in Chandigarh: a community-based study. J Gastroenterol Hepatol 2001; 16: 560-563 [PMID: 11350554]
40. Costantini R, Caldaralo F, Palmieri C, Napolitano L, Aceto L, Cellini C, Innocenti P. Risk factors for conversion of laparoscopic cholecystectomy. Ann Ital Chir 2012; 83: 245-252 [PMID: 22610122]